Bone Marrow TransplantationTransplantation, AutologousBone MarrowBone Marrow PurgingBone Marrow CellsTransplantation, HomologousWhole-Body IrradiationCombined Modality TherapyCyclophosphamideCarmustineLymphoma, Non-HodgkinGraft vs Host DiseaseTissue DonorsHematopoietic Stem Cell TransplantationMelphalanTransplantation ConditioningHistocompatibility TestingAntineoplastic Combined Chemotherapy ProtocolsLeukemiaRemission InductionBusulfanEtoposideHodgkin DiseaseHematopoietic Stem CellsLeukemia, Myeloid, AcuteRecurrenceHistocompatibilityCytarabineGraft SurvivalAnemia, AplasticBone Marrow DiseasesColony-Forming Units AssayTreatment OutcomeBone and BonesLeukemia, MyeloidHematopoiesisActuarial AnalysisPrecursor Cell Lymphoblastic Leukemia-LymphomaSurvival AnalysisVincristinePodophyllotoxinTime FactorsDrug EvaluationLiver TransplantationTransplantation ChimeraAcute DiseaseLymphomaDisease-Free SurvivalSalvage TherapyThiotepaSurvival RateTransplantation, IsogeneicImmunosuppressionLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukocyte CountFollow-Up StudiesHLA AntigensStem Cell TransplantationRetrospective StudiesGranulocyte Colony-Stimulating FactorGraft vs Host ReactionBone Marrow ExaminationLeukocyte TransfusionT-LymphocytesMyelodysplastic SyndromesHematologic NeoplasmsLymphatic IrradiationLiving DonorsMultiple MyelomaPrednisoneMitoxantroneGranulocyte-Macrophage Colony-Stimulating FactorTissue and Organ ProcurementKidney TransplantationGraft RejectionGranulocytesPrognosisPlatelet CountBlood Cell CountMice, Inbred C57BLBone Marrow NeoplasmsRadiation ChimeraHepatic Veno-Occlusive DiseaseNeuroblastomaBlood DonorsAntibodies, MonoclonalDoxorubicinMesnaGonadal DisordersImmunosuppressive AgentsOvarian Function TestsCyclosporineHematologic DiseasesProspective StudiesNeutropeniaRicinCell SeparationPrednimustineLymphoma, FollicularAgranulocytosis